Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × brostallicin × Clear all

Phase

Status

Sponsor Class

OTHER 2 NETWORK 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Liposarcoma, Myxoid 1

Interventions

pembrolizumab 850 Carboplatin 795 Paclitaxel 783 Gemcitabine 653 Cisplatin 632 Docetaxel 589 Bevacizumab 510 Pemetrexed 410 Cyclophosphamide 403 Nivolumab 396 Capecitabine 381 Fluorouracil 333 Dexamethasone 327 Rituximab 318 Oxaliplatin 283 Injections 282 atezolizumab 251 Trastuzumab 245 Cetuximab 232 Leucovorin 230 Irinotecan 216 Prednisone 214 130-nm albumin-bound paclitaxel 214 Doxorubicin 210 Ipilimumab 187 Lenalidomide 186 fludarabine 180 Fulvestrant 180 durvalumab 171 venetoclax 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00633165 2010-02-26

SMI-BRS-202

Systems Medicine LLC

Phase 2 Unknown

Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡